Gracell Biotechnologies Inc. (GRCL) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts GRCL Hot Sheet
Join SI Premium – FREE
Gracell Biotechnologies Inc. (NASDAQ: GRCL) reported Q4 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Gracell Biotechnologies Inc. (GRCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
